Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Daptomycin Prophylaxis in Two-Stage Exchange Arthroplasty
NCT06189885Not yet recruiting
- Sponsor
- Chang Gung Memorial Hospital
- Start
- Aug 2024
- Primary completion
- Jul 2026
- Modality
- Cyclic Peptides, Antimicrobial Peptides, Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of daptomycin in periprosthetic joint infection (PJI) (2 arms), sponsored by Chang Gung Memorial Hospital. Primary endpoint: Infection at 1 year. Planned start Aug 2024; status: not yet recruiting.
02
Drugs
daptomycin
03
Conditions
periprosthetic joint infection (PJI)
Beyond the preview
Go deeper on NCT06189885.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06189885.